CUAMC
PRTK

China Universal Asset Management Company’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

China Universal Asset Management Company’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-514
Closed -$1K – 491
2022
Q3 		$1K Buy
+514
New +$1.28K ﹤0.01% 430

Other funds holding PRTK

AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
GAI
General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BC
Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return

China Universal Asset Management Company's PRTK Position: Q4 2022 in Review

China Universal Asset Management Company sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q4 2022, closing a stake of 514 shares — an estimated $1K sold.

China Universal Asset Management Company first reported a position in PRTK in Q3 2022 and held it in 1 quarter. The position peaked at $1K in Q3 2022. 76 funds tracked by Wall St. Rank hold PRTK as of Q4 2022.

  • China Universal Asset Management Company reported no remaining Paratek Pharmaceuticals, Inc. position as of Q4 2022 after selling out during the quarter.
  • China Universal Asset Management Company sold 514 Paratek Pharmaceuticals, Inc. shares in Q4 2022, an estimated $1K.
  • China Universal Asset Management Company first reported a position in Paratek Pharmaceuticals, Inc. in Q3 2022 and held it in 1 quarter.
  • China Universal Asset Management Company's Paratek Pharmaceuticals, Inc. position peaked at $1K in Q3 2022.
  • 76 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q4 2022.

Based on China Universal Asset Management Company's 13F filing for Q4 2022, filed 31 Jan 2023.